OWD
BIIB icon

Osborn Williams & Donohoe’s Biogen BIIB Stock Holding History

Osborn Williams & Donohoe’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-900
Closed -$210K – 307
2019
Q2 		$210K Sell
900
-3,315
-79% -$765K 0.02% 306
2019
Q1 		$986K Buy
+4,215
New +$1.33M 0.1% 179

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Osborn Williams & Donohoe's BIIB Position: Q3 2019 in Review

Osborn Williams & Donohoe sold out of Biogen (BIIB) in Q3 2019, closing a stake of 900 shares — an estimated $210K sold.

Osborn Williams & Donohoe first reported a position in BIIB in Q1 2019 and held it in 2 quarters. The position peaked at $986K in Q1 2019. 988 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

  • Osborn Williams & Donohoe reported no remaining Biogen position as of Q3 2019 after selling out during the quarter.
  • Osborn Williams & Donohoe sold 900 Biogen shares in Q3 2019, an estimated $210K.
  • Osborn Williams & Donohoe first reported a position in Biogen in Q1 2019 and held it in 2 quarters.
  • Osborn Williams & Donohoe's Biogen position peaked at $986K in Q1 2019.
  • 988 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Osborn Williams & Donohoe's 13F filing for Q3 2019, filed 16 Oct 2019.